Back to search

Poland· PL-100361640

Furagina APTEO MED

A furazidin product containing furazidinum, registered in Poland by Synoptis Pharma Sp. z o.o..

ATC J01XE03

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedFuragina APTEO MEDATCJ01XE03REGISTER NO.PL-100361640PACKS LISTED1CHECKEDSeptember 27, 2026

The record

At a glance

URPL (Poland)
Active substance
Furazidinum
Manufacturer
Synoptis Pharma Sp. z o.o.
Country
Poland (PL)
ATC code
J01XE03
ATC class
Furazidin
Defined daily dose
0.3 g, O
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991322649

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/1eaedeb9-3ee9-4704-a453-eb7491ca36f0
GET /v1/drugs/1eaedeb9-3ee9-4704-a453-eb7491ca36f0?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki",
  "source": "urpl",
  "strength": "50 mg",
  "packaging": "05909991322649 ¦ OTC ¦ 113606\n30 tabl.",
  "substance": "Furazidinum 50 mg",
  "common_name": "Furazidinum",
  "pl_product_id": "100361640",
  "pozwolenie_nr": "23856",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}

See everything about furazidin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.